← Back to home

NEOPLASMS OF CONNECTIVE AND SOFT TISSUE WITH AN UNSPECIFIED ANATOMICAL SITE

Clinical trials for NEOPLASMS OF CONNECTIVE AND SOFT TISSUE WITH AN UNSPECIFIED ANATOMICAL SITE explained in plain language.

Never miss a new study

Get alerted when new NEOPLASMS OF CONNECTIVE AND SOFT TISSUE WITH AN UNSPECIFIED ANATOMICAL SITE trials appear

Sign up with your email to follow new studies for NEOPLASMS OF CONNECTIVE AND SOFT TISSUE WITH AN UNSPECIFIED ANATOMICAL SITE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

New hope for sarcoma patients: drug combo aims to shrink tumors

Disease control Not yet recruiting

This study tests whether adding a drug called bevacizumab (Onbevzi) to standard chemotherapy (gemcitabine and docetaxel) can shrink tumors better than chemotherapy alone in people with advanced soft tissue sarcoma. About 92 adults whose sarcoma has returned after 1-2 prior treatm…

Matched conditions: NEOPLASMS OF CONNECTIVE AND SOFT TISSUE WITH AN UNSPECIFIED ANATOMICAL SITE

Phase: PHASE2 • Sponsor: Yonsei University • Aim: Disease control

Last updated May 17, 2026 07:59 UTC

NEOPLASMS OF CONNECTIVE AND SOFT TISSUE WITH AN UNSPECIFIED ANATOMICAL SITE

Get alerted when new NEOPLASMS OF CONNECTIVE AND SOFT TISSUE WITH AN UNSPECIFIED ANATOMICAL SITE trials appear

New hope for sarcoma patients: drug combo aims to shrink tumors